ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

In brief: Shalala Meets HIV-Infected Children; Einstein’s Kornblith Moves To PCI; Yang Leaves Center

March 12, 1993

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

In Brief: New Clinical Oncology RFP Ready Soon; CCIRC, Joftes Agree On Funding Method For Symposia

March 9, 1979

NCAB Approves Fallout Study On Split Vote

March 13, 1981

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001